Lois Levine, Associate Editorial Director

Clinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.

A biologic from Germany offers a new treatment option for a number of dermatologic conditions.

At the RAD 2022 Conference, Steve Xu, MD, MSc, explains how a wearable sensor can better track the progression of atopic dermatitis while a patient is sleeping.

A 2022 RAD Conference abstract presentation showed the epidemiology of type 2 associated conditions included in patients with AD.

At the 2022 RAD Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.

Raj Chovatiya, MD, PhD, gives a preview of his discussions on topical formulations of atopic dermatitis and advancing therapeutic expectations at this weekend’s RAD conference.

Korey Capozza, MPH, Executive Director of Global Parents for Eczema Research, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.

Jonathan Silverberg, MD, PHD, MPHS, talks about the exciting highlights of the Revolutionizing Atopic Dermatitis virtual conference on December 11.

David Goldberg, MD, JD, shares some of the highlights that will be presented at this year's South Beach Symposium in Miami Beach, Florida.

Christopher Bunick, MD, discusses what to expect at the South Beach Symposium, February 9-12 in Miami Beach, Florida.

The author of a new study on JAK inhibitors discusses his surprising findings on the safety profiles of these new medications for dermatologic conditions.

At the 2022 Fall Clinical Dermatology Conference, a dermatologist shares results of using cemiplimab-rwlc (Libtayo) for basal and squamous cell carcinoma.

At the 2022 Fall Clinical Dermatology Conference, one clinician discusses history, definitions, and diagnosis for this common skin affliction.

At the 2022 Fall Clinical Dermatology Conference, 5 practitioners share their best tips for treating their patients

At the 2022 Fall Clinical Dermatology Conference,a presenter looks at the best treatments for hair loss and nail fungus.

At the 2022 Fall Clinical Dermatology Conference in Las Vegas, Aaron S. Farberg, MD, shares data on the treatment of plaque psoriasis using tildrakizumab-asmn.

At a session at the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss some of the top testing methods for skin cancer.

At the 2022 Fall Clinical Dermatology Conference, a look at the latest treatments for monkeypox, HIV, and more.

At the 2022 Fall Clinical Conference in Las Vegas, Nevada, Dermatology Times editor-in-chief, Zoe Diana Draelos, discusses her session on the latest trends in cosmeceuticals.

At the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss the best skin cleanser recommendations for their patients.

At the 2022 Fall Clinical Dermatology Conference in Las Vegas, a look at the latest technology for treating basal cell carcinoma and nonmelanoma skin cancer.

At a poster session at the Skin of Color Update meeting in New York City, investigators looked at skin cancer education and prevention among patients with skin of color.

At the 2022 Skin of Color Update meeting in New York City, Saakshi Khattri, MD, talks about the benefits of treating patients who have psoriasis with roflumilast cream.

At the Skin of Color Update meeting in New York City, Mona Shahriari, MD, FAAD, shares her thoughts on prescribing the recently-approved tapinarof (VTAMA) for plaque psoriasis.

At a poster session at the Skin of Color Update meeting in New York City, a study looked at whether women of color thought they were well-represented when it comes to learning about skin aging and prevention.

At the Skin of Color Update 2022 meeting, Pearl Grimes, MD, shares her thoughts on the recent approval of ruxolitinib cream.

Hilary Baldwin, MD, discusses what's new and exciting at the Skin of Color Update Meeting in NYC